Instem Presents at CDISC Europe Interchange
Instem Discusses Key Differentiators Between Preclinical and Clinical Electronic Study Data Submissions
CONSHOHOCKEN, PA – May 2, 2016 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has participated in the CDISC Europe Interchange, April 25 – 29 in Vienna, Austria.
Instem Executive Vice President of Regulatory eStudy Solutions, Mike Harwood, presented Preclinical Studies – Not Just Clinical Studies with Animals Or Why Preclinical has it easier than Clinical on Thursday, April 28. The talk reviewed the differences between preclinical and clinical study/trial planning and reporting, including a comparison of SEND 3.0 with SDTM 1.4. The presentation also reviewed the state of readiness within the preclinical community along with the status of, and plans for SEND. Finally, Mr. Harwood introduced ideas for strengthening the relationship between preclinical and clinical through improvements in collaboration and processes. The presentation was designed to both educate and foster dialogue between the two communities.
The CDISC Europe Interchange took place at the Austria Trend Hotel Savoyen in Vienna and welcomed over 300 attendees from around the world. More information about the CDISC Europe Interchange can be found at: http://www.cdisc.org/interchange.
Instem’s submit™-SEND tools and services are the most widely adopted in the industry, operating at over 34 sites across 12 countries. The Instem team has led and participated in the creation of the SEND standard for over 10 years and brings over 30 years of experience in developing, delivering and supporting world-class nonclinical systems and solutions for the scientific community.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 450 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600